[ad_1]
Reuters
Photo from the archives
CEO of US pharmaceutical company “Pfizer” Albert Burla sold his shares in the company for $ 5.6 million, after the share price jumped after a positive report on the effectiveness of the company’s vaccine against Corona.
The shares were sold on Monday, as the price per share reached $ 41.94, in the context of the publication of a positive report on a vaccine against the Corona virus that the company is developing in cooperation with the German company “Biontech “.
It should be noted that after the sale, Pfizer’s share declined, to close Monday’s trading at $ 38.5.
Pfizer has defended the sale by its CEO of 132,508 near-maximum value shares, saying in a statement that the deal was reached in August “as part of Dr. Burla’s personal financial planning”, in accordance with a plan previously established allowing “major shareholders and insiders to Publicly traded companies have traded a specified number of shares at a predetermined time.
Besides the CEO, his deputy, Sally Solman, also sold $ 1.8 million of shares she owns in the company.
In a related context, 90% of Americans have said they are unlikely to receive the Pfizer vaccine, for fear that it will be politicized or introduced without adequate safety testing.
Source: RT
[ad_2]
Source link
